Unmet personal patient needs in psoriasis patients with low disease activity on adalimumab, etanercept or ustekinumab
mediaposted on 2021-02-22, 22:16 authored by Marloes Elise van Muijen, Selma Atalay, Lieke Jane van Vugt, Laura Marie Danielle Vandermaesen, Juul Maria Petronella Antonia van den Reek, Elke Maria Gerarda Josepha de Jong
Article full text
The above Plain Language Summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.